In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ligand Pharmaceuticals, Inc.

http://www.ligand.com

Latest From Ligand Pharmaceuticals, Inc.

Digital Health Roundup: HLTH2022 Highlights, EU Updates, Diabetes Medtech Monthly

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb provides highlights from the recent HLTH conference in Las Vegas. Reed Miller and Barnaby Pickering offer an overview of the highly competitive diabetes tech market. We also talk about digital health in Germany and Europe.

Digital Health Innovation

HLTH 2022 Roundup: CEOs Of BD And Google Cloud On Innovation, Interoperability, AI

In this second roundup of HLTH, which drew more than 9,000 attendees to Las Vegas from 13-16 November, Medtech Insight highlights presentations from the CEOs of BD and Google Cloud and insights from an interview with BD’s CEO Tom Polen.

Digital Health Innovation

HLTH 2022 Roundup: Mirvie, Grail, Biofourmis, Komodo Health, Babson Diagnostics

This year’s annual HLTH meeting drew more than 9,000 people to Las Vegas from 13-16 November and hundreds of exhibitors. In this first part of a two-part roundup, Medtech Insight highlights interviews with C-suite executives at Mirvie, Grail, Biofourmis, Komodo Health and Babson Diagnostics.

Innovation Digital Health

HLTH Conference Promises Festival Vibe On One Big Stage; Health Equity, Women’s Health, Digital Health

HLTH is expected to draw more than 9,500 attendees to Las Vegas from 13-16 November.

Digital Health Innovation
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
      • Site Specific
  • Biotechnology
    • Drug Discovery Tools
    • Transgenics
    • Large Molecule
      • Antibodies
  • Other Names / Subsidiaries
    • Ab Initio Biotherapeutics
    • Crystal Bioscience, Inc.
    • CyDex Pharmaceuticals, Inc.
    • Icagen Pharmaceuticals, Inc.
    • Metabasis Therapeutics, Inc.
    • Neurogen Corporation
    • Pharmacopeia, Inc.
    • Pfenex Inc.
    • Verrow Pharmaceuticals, Inc.
    • Vernalis Group plc
    • Cita NeuroPharmaceuticals
    • Taurus Biosciences LLC
    • xCella Biosciences, Inc.
UsernamePublicRestriction

Register